{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-008530","form_type":"8-K","ticker":"ODYY","cik":"0001626644","company_name":"Odyssey Health, Inc.","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.970690+00:00","generated_at":"2026-05-16T18:28:10.697547+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Odyssey Health secures up to $25M financing facility and 9-year service contract","bullets":["Entered Maintenance Agreement with Mast Hill Fund; issued $2.262M convertible note at 10% interest due Nov 2026.","Securities Purchase Agreement provides up to $25M in multiple tranches; first tranche $500K with $437,500 net proceeds.","Initial $500K tranche directed to BreastCheck® sub-licensing program.","Service contract generates ~$245K/year recurring revenue through Feb 2034.","Convertible notes and warrants issuable at 85% of lowest VWAP over prior 10 trading days."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-008530","json":"https://secwatch.observer/filing/0001683168-25-008530.json","markdown":"https://secwatch.observer/filing/0001683168-25-008530.md","text":"https://secwatch.observer/filing/0001683168-25-008530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626644/000168316825008530/0001683168-25-008530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626644/000168316825008530/odyssey_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:28:10.697547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15bee7efc285810f05955b04680031e568629abf","claim":"Odyssey Health, Inc. incurred convertible notes of up to $25,000,000 with Mast Hill Fund, L.P. at OID of 10% on each tranche.","evidence_excerpt":"the Company may issue a promissory note with a maximum principal amount of up to $25,000,000 in multiple tranches","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626644/000168316825008530/0001683168-25-008530-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"up to $25,000,000"},{"label":"Counterparty","value":"Mast Hill Fund, L.P."},{"label":"Rate","value":"OID of 10% on each tranche"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"4564feceb2a41df537c4a62d165355c683e5bd62","claim":"Odyssey Health, Inc. incurred convertible notes of $2,262,000 with Mast Hill Fund, L.P. at 10% per annum maturing November 13, 2026.","evidence_excerpt":"the Company issued to MHF a convertible promissory note in the original principal amount of $2,262,000 which bears interest at 10% per annum and is due November 13, 2026","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626644/000168316825008530/0001683168-25-008530-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$2,262,000"},{"label":"Counterparty","value":"Mast Hill Fund, L.P."},{"label":"Rate","value":"10% per annum"},{"label":"Maturity","value":"November 13, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}